These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 8406388)

  • 1. An immunophenotypic survey of malignant melanomas.
    Bishop PW; Menasce LP; Yates AJ; Win NA; Banerjee SS
    Histopathology; 1993 Aug; 23(2):159-66. PubMed ID: 8406388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans.
    Ma CK; Zarbo RJ; Gown AM
    Am J Clin Pathol; 1992 Apr; 97(4):478-83. PubMed ID: 1553911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
    Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
    Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
    Hitzer S; Bialasiewicz AA; Richard G
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Grossniklaus HE; Orcutt J; Kalina RE; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Dec; 120(12):1625-9. PubMed ID: 12470134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
    Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
    Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic signet-ring cell melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical, and ultrastructural findings.
    Eckert F; Baricević B; Landthaler M; Schmid U
    J Am Acad Dermatol; 1992 May; 26(5 Pt 2):870-5. PubMed ID: 1613153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
    Eyden B; Pandit D; Banerjee SS
    Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
    Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
    Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and immunophenotypic variations in malignant melanoma.
    Banerjee SS; Harris M
    Histopathology; 2000 May; 36(5):387-402. PubMed ID: 10792480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic differences between uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
    Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
    Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of malignant melanoma expressing epithelial cell markers in immunohistochemistry using paraffin sections].
    Toublanc M; Grossin M; Benrejeb N; Tousignant J; Crickx B; Belaich S; Bocquet L
    Ann Pathol; 1990; 10(1):34-6. PubMed ID: 2328064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
    Duray PH; Palazzo J; Gown AM; Ohuchi N
    Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.